What is the fair value of Bayer AG PK (OTC-BAYR.Y) stock?

The current fair value estimate for Bayer AG PK (OTC-BAYR.Y) is $14.65. This implies an estimated upside of 3.3% versus the current market price.

Is Bayer AG PK (OTC-BAYR.Y) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 3.3% versus the current market price.

What is the analyst price target for OTC-BAYR.Y stock?

The available analyst price target for Bayer AG PK (OTC-BAYR.Y) is $15.89. The analyst target implies estimated upside of 12.1%.

How is the financial health of Bayer AG PK?

The current financial health read for Bayer AG PK (OTC-BAYR.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Bayer AG PK's next earnings date?

The next earnings date currently listed for Bayer AG PK (OTC-BAYR.Y) is November 3, 2026.

Does Bayer AG PK (OTC-BAYR.Y) pay dividends?

Based on the current data, dividend yield is 0.2%.

What is the market capitalization of Bayer AG PK?

The current market capitalization listed for Bayer AG PK is 55.735 B.

What is the enterprise value of Bayer AG PK?

The current enterprise value listed for Bayer AG PK is 89.789 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Bayer AG PK?

The ticker symbol for Bayer AG PK is OTC-BAYR.Y, and the stock is listed on OTC Markets.

Where is Bayer AG PK (OTC-BAYR.Y) listed?

Bayer AG PK (OTC-BAYR.Y) is listed on OTC Markets.

What is the debt-to-total-capital ratio for Bayer AG PK?

The current debt-to-total-capital ratio listed for Bayer AG PK is 44.3%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Bayer AG PK?

The free float listed for Bayer AG PK is 100.0%. Free float helps investors understand how much of the share base is available for public trading.

Bayer AG PK (BAYRY) Fair Value & Stock Analysis

Bayer AG PK (BAYRY)

Bayer AG PK is an ADR representing common stock of Bayer Aktiengesellschaft, listed on OTC Markets. The underlying issuer is a life science company with operations across Europe, the Middle East, Africa, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. Bayer operates through three business segments: Pharmaceuticals, Consumer Health, and Crop Science. Its pharmaceutical business includes prescription medicines in cardiology and women’s health, specialty therapies in oncology, hematology, and ophthalmology, as well as diagnostic imaging products, contrast agents, and cell and gene therapy. The Consumer Health segment sells over-the-counter medicines and products for nutrition, allergies, cough and cold, dermatology, pain management, cardiovascular risk prevention, and digestive health. Crop Science supplies chemical and biological crop protection products, seeds, improved plant traits, digital tools, and pest and weed management solutions. Bayer was founded in 1863 and is based in Leverkusen, Germany.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
OTC-BAYR.Y	$14.65	3.3% Upside	Fair	$15.89	12.1% Upside	Fair	Good	0.2%	November 3, 2026	1.6x	1.1x	55.735 B	89.789 B	44.3%	100.0%	4.4	-6.2%	-119.6%